Marlowe plc (LON:MRL – Get Free Report) insider Peter M. R. Gaze bought 15,000 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The stock was purchased at an average price of GBX 309 ($4.14) per share, with a total value of £46,350 ($62,064.81).
Marlowe Price Performance
MRL stock traded up GBX 6 ($0.08) during mid-day trading on Monday, hitting GBX 321 ($4.30). The stock had a trading volume of 2,521,703 shares, compared to its average volume of 613,450. The firm has a fifty day simple moving average of GBX 438.78 and a 200 day simple moving average of GBX 483.60. The firm has a market capitalization of £282.48 million, a P/E ratio of -2,236.05 and a beta of 0.44. The company has a current ratio of 1.24, a quick ratio of 0.80 and a debt-to-equity ratio of 58.99. Marlowe plc has a 52 week low of GBX 220 ($2.95) and a 52 week high of GBX 620 ($8.30).
Wall Street Analyst Weigh In
MRL has been the topic of several research analyst reports. Royal Bank of Canada reissued an “outperform” rating and issued a GBX 690 ($9.24) price objective on shares of Marlowe in a research report on Thursday, August 1st. Berenberg Bank reissued a “buy” rating and issued a GBX 710 ($9.51) price target on shares of Marlowe in a report on Wednesday, August 21st.
About Marlowe
Marlowe plc provides compliance services and software in the United Kingdom. The company operates in two segments, Governance, Risk and Compliance; and Testing, and Inspection and Certification. It offers health and safety consultancy, risk and audit assessments, environmental, contractor management, and training services; and health and safety support services.
Featured Stories
- Five stocks we like better than Marlowe
- CD Calculator: Certificate of Deposit Calculator
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- How to Invest in Biotech Stocks
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for Marlowe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marlowe and related companies with MarketBeat.com's FREE daily email newsletter.